128
Participants
Start Date
October 31, 2014
Primary Completion Date
November 30, 2016
Study Completion Date
February 16, 2017
Lanreotide Autogel®
Lanreotide Autogel 60mg, 90mg, and 120mg, pre-filled syringe, deep subcutaneous injection (provided as a supersaturated solution of lanreotide acetate).
Lanreotide Acetate
Lanreotide PR 40mg white freeze-drying cake, 40mg/vial, deep subcutaneous injection (provided as a sterile injectable lyophilisate of lanreotide acetate).
Peking Union Medical College Hospital, Beijing
Huashan Hospital Fudan University, Shanghai
Jiangsu Provincial People's Hospital, Nanjing
Tianjin Medical University General Hospital, Tianjin
Fujian Provincial Hospital, Fuzhou
Tongji Medical College Huazhong University of Science & Technology, Wuhan
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Affiliate Hospital of Guiyang Medical College, Guizhou
West China Hospital, Sichuan University, Chengdu
The Second Hospital of Hebei Medical University, Shijiazhuang
Lead Sponsor
Ipsen
INDUSTRY